| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
| LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| NPC1 |
O15118
|
NPC intracellular cholesterol transporter 1
|
Transporter
|
6.5E-06 |
0.518 |
0.692 |
| TP73 |
O15350
|
tumor protein p73
|
Transcription factor
|
1.00 |
0.449 |
0.808 |
| HPGDS |
O60760
|
hematopoietic prostaglandin D synthase
|
|
1.8E-06 |
0.388 |
0.923 |
| SH2D1A |
O60880
|
SH2 domain containing 1A
|
|
0.39 |
0.525 |
0.731 |
| TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
| EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
| MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
| TGFB1 |
P01137
|
transforming growth factor beta 1
|
Signaling
|
3.7E-02 |
0.287 |
0.962 |
| GH1 |
P01241
|
growth hormone 1
|
Signaling
|
3.0E-02 |
0.373 |
0.923 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
| IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
| HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
| APCS |
P02743
|
amyloid P component, serum
|
|
3.2E-02 |
0.531 |
0.808 |
| FN1 |
P02751
|
fibronectin 1
|
Signaling
|
1.4E-03 |
0.365 |
0.962 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |